In the STEP 1 trial extension, patients who lost an average of 17.3% of their body weight on semaglutide regained about two-thirds of that loss within a year of stopping the medication and lifestyle program (STEP 1 extension, PMC)
Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study
Seeking professional medical advice is always the best course of action to ensure the safest and most effective treatment
Research in this area has provided new diagnostic markers such as the microRNA miR-122 as well as mechanistic biomarkers associated with apoptosis, mitochondrial dysfunction, inflammation and tissue regeneration
It effectively counteracts the inherent ulcerogenic potential of various NSAIDs and provides protection even in conditions of ethanol stomach lesions, somatosensory neurons depletion, short bowel, and NOS-blockade